Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma
- Aarts, B. M.
- Prevoo, W.
- Meier, M. A. J.
- Bex, A.
- Beets-Tan, R. G. H.
- Klompenhouwer, E. G.
- Gomez, F. M.
Publication date
July 2020
DOIAbstract
Objectives To assess the safety and efficacy of percutaneous microwave ablation (MWA) of histologically proven T1 renal cell carcinoma (RCC). Methods We analysed patients with a histologically proven RCC ( 3-5 were observed (2 T1a, 4 T1b, p = 0.045). Multivariable analysis showed that mR.E.N.A.L. nephrometry was independently associated with incomplete ablation (p = 0.012). Conclusion Microwave ablation is safe and effective for T1a and T1b RCC lesions with a significantly lower primary efficacy for T1b lesions.</p
Add to ORKG